Design of NK-2-derived peptides with improved activity against equine sarcoid cells.

The research paper is about the development of enhanced peptides, derived from NK-2, that have shown increased effectiveness against equine sarcoid cells, a common form of skin tumor in horses.

Objective of the Research

• This research seeks to evaluate and enhance natural peptides for host defence and focuses primarily on the cationic and amphipathic peptide NK-2. The goal is to develop peptides with an ability to disrupt cell membranes of equine sarcoid cells, thereby preventing the progression of this form of skin tumor in horses.

Methodology

• The research made use of cytotoxicity tests, fluorescence microscopy, and a chip-based biosensor that allowed real-time monitoring of cell metabolism.
• The efficiency and interaction of these peptides with cancer cells were tested and monitored.

Findings

• The research found that the revised NK-2 peptides manifested a dynamic killing of cancer cells, involving first an increased cellular respiration phase and then a phase of membrane destruction.
• The improved NK-2 peptides were substantially more efficient against equine sarcoid cells, with a fivefold improvement in activity and no significant increase in haemolysis.

Lack of Selectivity

• The research highlighted a challenge of similar Zeta potential and similar amounts of surface phosphatidylserine found in both sarcoid cells and normal skin cells. This similarity makes it difficult to selectively target sarcoid cells without affecting normal cells, potentially leading to unwanted side effects.

Conclusion

• Despite the challenge of similar Zeta potential in normal skin and sarcoid cells, the study provides a promising path towards the design of effective anticancer peptides against equine sarcoids, paving the way for potential therapeutic interventions for this common equine skin condition.